eGain Q1 2026 Earnings EPS Beats Estimates by Over 54 Bolt Biotherapeutics Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage ATRA Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Progress Continues NVCR Q1 2026 Earnings EPS Misses Estimates by 1852 Despite Positive Stock Movement LBRDP Q3 2025 Earnings Strong EPS Surprise Highlights Resilient Performance VABK Q1 2026 Earnings EPS of 097 Highlights Steady Performance Amid Limited Disclosure